Skip to main content

Advertisement

SpringerLink
Log in

Production of anti TNF-α antibodies in eukaryotic cells using different combinations of vectors carrying heavy and light chains

  • Original Research
  • Published:
Cytotechnology Aims and scope Submit manuscript

Abstract

Tumor necrosis factor-α (TNF-α) plays a key role in rheumatoid arthritis and some other autoimmune diseases. Therapy with anti-TNF-α recombinant antibodies (Ab) appears to be highly effective. Production of new hyper-producing eukaryotic cell lines can decrease the treatment cost, which currently is very high. However, due to the complexity of protein transcription, translation, processing, and secretion in mammalian cells, the stages at which antibody expression is affected are still poorly determined. The aim of this work was to compare the productivity of two cell lines developed in CHO DG44 cells, deficient in dihydrofolate reductase, transfected with vectors carrying either heavy (H) or light (L) chains of chimeric antibody under different combinations of selective elements. Both H and L chains were cloned either in pOptiVEC or pcDNA3.3 vectors and different combinations were used to produce HL and LH cell lines. We have shown that Ab production has been low and comparable between HL and LH cells until selection on methotrexate (MTX) when LH but not HL cells have responded with 3.5 times increased productivity. Flow cytometry analysis has demonstrated that intracellular concentration of full size Abs in LH cells was 5.6 times higher than in HL ones due to higher amount of H chain synthesis. No differences in viability between HL and LH cells have been found. We have concluded that the expression of H chain in the pOptiVEC vector, which is responsible for MTX resistance, has led to the suppression of H chain synthesis and limitation in full Ab assembly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Baldi L, Muller N, Picasso S, Jacquet R, Girard P, Thanh HP, Derow E, Wurm FM (2005) Transient gene expression in suspension HEK-293 cells: application to large-scale protein production. Biotechnol Prog 21:148–153. doi:10.1021/bp049830x

    Article  CAS  Google Scholar 

  • Barnes LM, Bentley CM, Dickson AJ (2001) Characterization of the stability of recombinant protein production in the GS-NS0 expression system. Biotechnol Bioeng 73:261–270

    Article  CAS  Google Scholar 

  • Bianchi AA, McGrew JT (2003) High-level expression of full-length antibodies using trans-complementing expression vectors. Biotechnol Bioeng 84:439–444. doi:10.1002/Bit.10790

    Article  CAS  Google Scholar 

  • Davies SL, O’Callaghan PM, McLeod J, Pybus LP, Sung YH, Rance J, Wilkinson SJ, Racher AJ, Young RJ, James DC (2011) Impact of gene vector design on the control of recombinant monoclonal antibody production by Chinese hamster ovary cells. Biotechnol Prog 27:1689–1699. doi:10.1002/btpr.692

    Article  CAS  Google Scholar 

  • DeMaria CT, Cairns V, Schwarz C, Zhang J, Guerin M, Zuena E, Estes S, Karey KP (2007) Accelerated clone selection for recombinant CHO CELLS using a FACS-based high-throughput screen. Biotechnol Prog 23:465–472. doi:10.1021/bp060298i

    Article  CAS  Google Scholar 

  • Dwek RA (1995) Glycobiology: “towards understanding the function of sugars”. Biochem Soc Trans 23:1–25

    Article  CAS  Google Scholar 

  • Gaillet B, Gilbert R, Amziani R, Guilbault C, Gadoury C, Caron AW, Mullick A, Garnier A, Massie B (2007) High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch. Biotechnol Prog 23:200–209. doi:10.1021/bp060187j

    Article  CAS  Google Scholar 

  • Gomez N, Subramanian J, Ouyang J, Nguyen MD, Hutchinson M, Sharma VK, Lin AA, Yuk IH (2012) Culture temperature modulates aggregation of recombinant antibody in cho cells. Biotechnol Bioeng 109:125–136. doi:10.1002/bit.23288

    Article  CAS  Google Scholar 

  • Goochee CF, Monica T (1990) Environmental effects on protein glycosylation. Biotechnol (NY) 8:421–427

    Article  CAS  Google Scholar 

  • Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77(1):51–59

  • Hu S, Deng L, Wang H, Zhuang Y, Chu J, Zhang S, Li Z, Guo M (2011) Bioprocess development for the production of mouse-human chimeric anti-epidermal growth factor receptor vIII antibody C12 by suspension culture of recombinant Chinese hamster ovary cells. Cytotechnology 63:247–258. doi:10.1007/s10616-011-9336-y

    Article  CAS  Google Scholar 

  • Jayapal KP, Wlaschin KF, Hu WS, Yan MGS (2005) Recombinant protein therapeutics from CHO cells—20 years and counting. CHO Consortium, SBE special section: 40–47

  • Jenkins N, Curling EM (1994) Glycosylation of recombinant proteins: problems and prospects. Enzyme Microb Technol 16:354–364

    Article  CAS  Google Scholar 

  • Jiang Z, Huang Y, Sharfstein ST (2006) Regulation of recombinant monoclonal antibody production in Chinese hamster ovary cells: a comparative study of gene copy number, mRNA level, and protein expression. Biotechnol Prog 22:313–318. doi:10.1021/bp0501524

    Article  CAS  Google Scholar 

  • Khoo SH, Rubeai KM (2008) Detailed understanding of enhanced specific antibody productivity in NS0 myeloma cells. Biotechnol Bioeng 102:188–199

    Article  Google Scholar 

  • Kim DY, Lee JC, Chang HN, Oh DJ (2006) Development of serum-free media for a recombinant CHO cell line producing recombinant antibody. Enzyme Microb Technol 39:426–433. doi:10.1016/j.enzmictec.2005.11.047

    Article  CAS  Google Scholar 

  • Kohler G (1980) Immunoglobulin chain loss in hybridoma lines. Proc Natl Acad Sci USA 77:2197–2199

    Article  CAS  Google Scholar 

  • Kunert R, Steinfellner W, Purtscher M, Assadian A, Katinger H (2000) Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells. Biotechnol Bioeng 67:97–103

    Article  CAS  Google Scholar 

  • Li JM, Chen W, Jia XJ, An XP, Li B, Fan YR, Tong YG (2005) Expression of human-mouse chimeric antibody directed against Chikungunya virus with site-specific integration system. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 21:312–315, 318

  • Lonza Cologne AG (2009) Lonza Bio. optimized protocol for suspension CHO clones. http://bio.lonza.com/fileadmin/groups/marketing/Downloads/Protocols/Generated/Optimized_Protocol_111.pdf

  • Mounach A, Rezqi A, Nouijai A, Ghozlani I, Achemlal L, Maghraoui AE, Bezza A (2013) Stevens-Johnson syndrome complicating adalimumab therapy in rheumatoid arthritis disease. Rheumatol Int 33:1351–1353. doi:10.1007/s00296-011-2212-4

    Article  CAS  Google Scholar 

  • Page MJ, Sydenham MA (1991) High level expression of the humanized monoclonal antibody Campath-1H in Chinese hamster ovary cells. Biotechnol (NY) 9:64–68

    Article  CAS  Google Scholar 

  • Pichler J, Galosy S, Mott J, Borth N (2011) Selection of CHO host cell subclones with increased specific antibody production rates by repeated cycles of transient transfection and cell sorting. Biotechnol Bioeng 108:386–394. doi:10.1002/bit.22946

    Article  CAS  Google Scholar 

  • Radko BV, Boitchenko VE, Nedospasov SA, Korobko VG (2002) Characterization of the genes encoding variable light and heavy chains of the high-affinity monoclonal antibody against human tumor necrosis factor. Russ J Immunol 7:371–374

    CAS  Google Scholar 

  • Sambrook J, MacCallum P, Russell D (2001) Molecular cloning: a laboratory manual. 3rd. Cold Spring Harbor Press, NY. 1: 107–111

  • Schlatter S, Stansfield SH, Dinnis DM, Racher AJ, Birch JR, James DC (2005) On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells. Biotechnol Prog 21:122–133. doi:10.1021/bp049780w

    Article  CAS  Google Scholar 

  • Schroder M, Kaufman RJ (2005) The mammalian unfolded protein response. Annu Rev Biochem 74:739–789. doi:10.1146/annurev.biochem.73.011303.074134

    Article  Google Scholar 

  • Schutt C, Furll B, Stelter F, Jack RS, Witt S (1997) CHO transfectants produce large amounts of recombinant protein in suspension culture. J Immunol Method 204:99–102. doi:10.1016/S0022-1759(97)00027-6

    Article  CAS  Google Scholar 

  • Shingarova LN, Boldyreva EF, Yakimov SA, Guryanova SV, Dolgikh DA, Nedospasov SA, Kirpichnikov MP (2010) Novel mutants of human tumor necrosis factor with dominant-negative properties. Biochemistry (Mosc) 75:1458–1463

    Article  CAS  Google Scholar 

  • Sizova LV (2011) Treatment of early arthritis using arthrofoon (ultra-low doses of antibodies to tumor necrosis factor-α). Indian J Pharmacol 43:724–725. doi:10.4103/0253-7613.89836

    CAS  Google Scholar 

  • Sung YH, Lim SW, Chung JY, Lee GM (2004) Yeast hydrolysate as a low-cost additive to serum-free medium for the production of human thrombopoietin in suspension cultures of Chinese hamster ovary cells. Appl Microbiol Biotechnol 63:527–536. doi:10.1007/s00253-003-1389-1

    Article  CAS  Google Scholar 

  • Trill JJ, Shatzman AR, Ganguly S (1995) Production of monoclonal antibodies in COS and CHO cells. Curr Opin Biotechnol 6:553–560

    Article  CAS  Google Scholar 

  • Utsumi J, Mizuno Y, Hosoi K, Okano K, Sawada R, Kajitani M, Sakai I, Naruto M, Shimizu H (1989) Characterization of four different mammalian-cell-derived recombinant human interferon-beta 1 s: identical polypeptides and non-identical carbohydrate moieties compared to natural ones. Eur J Biochem 181:545–553

    Article  CAS  Google Scholar 

  • Zhou W, Chen CC, Buckland B, Aunins J (1997) Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production. Biotechnol Bioeng 55:783–792. doi:10.1002/(SICI)1097-0290(19970905)55:5<783::AID-BIT8>3.0.CO;2-7

    Article  CAS  Google Scholar 

  • Zuberbuhler K, Palumbo A, Bacci C, Giovannoni L, Sommavilla R, Kaspar M, Trachsel E, Neri D (2009) A general method for the selection of high-level scFv and IgG antibody expression by stably transfected mammalian cells. Protein Eng Des Sel 22:169–174. doi:10.1093/protein/gzn068

    Article  Google Scholar 

Download references

Acknowledgments

This work was performed under State Research Contract #16.512.11.2170 funded by the Ministry of Education and Science of the Russian Federation. The work is supported in part by RAS Program “Molecular and Cellular Biology”.

Author information

Authors and Affiliations

  1. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, RAS, GSP-7, Miklukho-Maklaya, 16/10, 117997, Moscow, Russia

    Dmitriy Balabashin, Elena Kovalenko, Viktoria Toporova, Teimur Aliev, Anna Panina, Elena Svirshchevskaya, Dmitry Dolgikh & Mikhail Kirpichnikov

  2. Lomonosov Moscow State University, GSP-1, Leninskie Gory, 119991, Moscow, Russia

    Dmitriy Balabashin, Viktoria Toporova, Teimur Aliev, Dmitry Dolgikh & Mikhail Kirpichnikov

Authors
  1. Dmitriy Balabashin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elena Kovalenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Viktoria Toporova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Teimur Aliev
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anna Panina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elena Svirshchevskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dmitry Dolgikh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mikhail Kirpichnikov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dmitriy Balabashin.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Balabashin, D., Kovalenko, E., Toporova, V. et al. Production of anti TNF-α antibodies in eukaryotic cells using different combinations of vectors carrying heavy and light chains. Cytotechnology 67, 761–772 (2015). https://doi.org/10.1007/s10616-014-9714-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10616-014-9714-3

Keywords

Search

Navigation